The Involvement of Mycobacterium Type III-A CRISPR-Cas System in Oxidative Stress

The Involvement of Mycobacterium Type III-A CRISPR-Cas System in Oxidative Stress

Type I and type II CRISPR-Cas systems are employed to evade host immunity by targeting interference of bacteria’s own genes. Although Mycobacterium tuberculosis (M. tuberculosis), the causative agent of tuberculosis, possesses integrated type III-A CRISPR-Cas system, its role in mycobacteria remains...

Full description

Bibliographic Details
Main Authors:	Fan Yang, Lingqing Xu, Lujie Liang, Wanfei Liang, Jiachen Li, Daixi Lin, Min Dai, Dianrong Zhou, Yaxin Li, Yong Chen, Hui Zhao, Guo-bao Tian, Siyuan Feng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-12-01
Series:	Frontiers in Microbiology
Subjects:	type III-A CRISPR-Cas Mycobacterium envelope integrity oxidative stress immunoregulation
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2021.774492/full

Similar Items

A CRISPR-guided mutagenic DNA polymerase strategy for the detection of antibiotic-resistant mutations in M. tuberculosis
by: Siyuan Feng, et al.
Published: (2022-09-01)

Single-Fluorescence ATP Sensor Based on Fluorescence Resonance Energy Transfer Reveals Role of Antibiotic-Induced ATP Perturbation in Mycobacterial Killing
by: Lujie Liang, et al.
Published: (2022-06-01)

MCR-1-dependent lipid remodelling compromises the viability of Gram-negative bacteria
by: Siyuan Feng, et al.
Published: (2022-12-01)

A new variant of the colistin resistance gene MCR-1 with co-resistance to β-lactam antibiotics reveals a potential novel antimicrobial peptide.
by: Lujie Liang, et al.
Published: (2023-12-01)

Involvement of Transcription Elongation Factor GreA in Mycobacterium Viability, Antibiotic Susceptibility, and Intracellular Fitness
by: Siyuan Feng, et al.
Published: (2020-03-01)

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
by: Fei Zhang, et al.
Published: (2019-06-01)

Regulation of CRISPR-Associated Genes by Rv1776c (CasR) in <i>Mycobacterium tuberculosis</i>
by: Wenping Wei, et al.
Published: (2023-02-01)

The future of CRISPR in Mycobacterium tuberculosis infection
by: Rima Zein-Eddine, et al.
Published: (2023-05-01)

A CRISPR-Assisted Nonhomologous End-Joining Strategy for Efficient Genome Editing in <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content>
by: Mei-Yi Yan, et al.
Published: (2020-02-01)

Mycobacterium PPE31 Contributes to Host Cell Death
by: Siyuan Feng, et al.
Published: (2021-04-01)

Critical roles for ‘housekeeping’ nucleases in type III CRISPR-Cas immunity
by: Lucy Chou-Zheng, et al.
Published: (2022-12-01)

A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
by: Lucy Chou-Zheng, et al.
Published: (2019-04-01)

The Application of the CRISPR-Cas System in Antibiotic Resistance
by: Tao S, et al.
Published: (2022-08-01)

CRISPR/Cas Genome Editing Technologies for Plant Improvement against Biotic and Abiotic Stresses: Advances, Limitations, and Future Perspectives
by: Yaxin Wang, et al.
Published: (2022-12-01)

EspB and HtpG interact with the type III-A CRISPR/Cas system of Mycobacterium tuberculosis
by: Mingmin Shi, et al.
Published: (2023-11-01)

Expanding CRISPR/Cas9 Genome Editing Capacity in Zebrafish Using SaCas9
by: Yan Feng, et al.
Published: (2016-08-01)

Comparative Genomic Analysis of <italic toggle="yes">Mycobacteriaceae</italic> Reveals Horizontal Gene Transfer-Mediated Evolution of the CRISPR-Cas System in the <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> Complex
by: Anoop Singh, et al.
Published: (2021-02-01)

Profiling the impact of the promoters on CRISPR-Cas12a system in human cells
by: Jinhe Li, et al.
Published: (2023-05-01)

Bioinformational analysis of Yersinia pseudotuberculosis IP32953 CRISPR/cas system
by: N. P. Peretolchina, et al.
Published: (2016-09-01)

CRISPR/Cas genome editing in grapevine: recent advances, challenges and future prospects
by: Chong Ren, et al.
Published: (2022-01-01)

CRISPR-Cas13a-Based Detection for Bovine Viral Diarrhea Virus
by: Rui Yao, et al.
Published: (2021-06-01)

CRISPR-Cas13 in malaria parasite: Diagnosis and prospective gene function identification
by: Elvis Quansah, et al.
Published: (2023-01-01)

Development and Application of CRISPR-Cas Based Tools
by: Yanping Hu, et al.
Published: (2022-04-01)

CRISPR-Cas13a system: A novel tool for molecular diagnostics
by: Lixin Zhao, et al.
Published: (2022-12-01)

A CRISPR-Cas12a-based platform for ultrasensitive rapid highly specific detection of Mycobacterium tuberculosis in clinical application
by: Nan Jia, et al.
Published: (2023-05-01)

Molecular mechanism of active Cas7-11 in processing CRISPR RNA and interfering target RNA
by: Hemant N Goswami, et al.
Published: (2022-10-01)

An improved plant CRISPR-Cas9 system for generating Cas9-free multiplex mutants
by: Jun-Li Wang, et al.
Published: (2021-01-01)

The CRISPR‐Cas13a Gene‐Editing System Induces Collateral Cleavage of RNA in Glioma Cells
by: Qixue Wang, et al.
Published: (2019-10-01)

Cold Cas: reevaluating the occurrence of CRISPR/Cas systems in Mycobacteriaceae
by: Evan Brenner, et al.
Published: (2023-06-01)

Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family
by: Li Liu, et al.
Published: (2022-09-01)

CRISPR-CasRx Targeting LncRNA LINC00341 Inhibits Tumor Cell Growth in vitro and in vivo
by: Chunjing Li, et al.
Published: (2021-03-01)

Upgrading of efficient and scalable CRISPR–Cas-mediated technology for genetic engineering in thermophilic fungus Myceliophthora thermophila
by: Qian Liu, et al.
Published: (2019-12-01)

Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid
by: Xiaoping Li, et al.
Published: (2023-09-01)

Application of the CRISPR/Cas System in Pathogen Detection: A Review
by: Bowei Yuan, et al.
Published: (2022-10-01)

CRISPR–Cas9 Based Bacteriophage Genome Editing
by: Xueli Zhang, et al.
Published: (2022-08-01)

Functional Features and Current Applications of the RNA‐Targeting Type VI CRISPR‐Cas Systems
by: Vanja Perčulija, et al.
Published: (2021-07-01)

The CRISPR/Cas9 System Delivered by Extracellular Vesicles
by: Xinglong Zhu, et al.
Published: (2023-03-01)

An Endogenous Staphylococcus aureus CRISPR-Cas System Limits Phage Proliferation and Is Efficiently Excised from the Genome as Part of the SCCmec Cassette
by: Kasper Mikkelsen, et al.
Published: (2023-08-01)

Advances in application of CRISPR-Cas13a system
by: Yue Zhang, et al.
Published: (2024-02-01)

CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma
by: Bryan D. Choi, et al.
Published: (2019-11-01)